Abbott LaboratoriesABTNYSE
Loading
SG&A Expenses Over TimeStrong
Percentile Rank93
3Y CAGR+3.7%
5Y CAGR+5.1%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+3.7%/yr
vs +3.5%/yr prior
5Y CAGR
+5.1%/yr
Consistent
Acceleration
+0.2pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $12.38B | +6.2% |
| 2024 | $11.65B | +7.1% |
| 2023 | $10.88B | -2.0% |
| 2022 | $11.11B | -1.5% |
| 2021 | $11.28B | +16.6% |
| 2020 | $9.67B | -0.3% |
| 2019 | $9.69B | +0.0% |
| 2018 | $9.69B | +8.1% |
| 2017 | $8.96B | +35.1% |
| 2016 | $6.64B | - |